Because melatonin is sold as a dietary supplement rather than a drug in the US, there is little to no quality control over the wide array of product types.
When huge companies assert their patents, smaller businesses and public plant breeders are dissuaded from conducting research that might not be illegal at all.
President Donald Trump signed executive orders to support the futuristic technology, with the aim of building a machine capable of scientific research by 2028.